These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 10650956)

  • 21. Molecular mimics of insulin-like growth factor 1 (IGF-1) for inhibiting IGF-1: IGF-binding protein interactions.
    Lowman HB; Chen YM; Skelton NJ; Mortensen DL; Tomlinson EE; Sadick MD; Robinson IC; Clark RG
    Biochemistry; 1998 Jun; 37(25):8870-8. PubMed ID: 9636028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potentiation of insulin-like growth factor (IGF) action by IGF-binding protein-3: studies of underlying mechanism.
    Conover CA
    Endocrinology; 1992 Jun; 130(6):3191-9. PubMed ID: 1375895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Secretion of insulin-like growth factor II (IGF-II) and IGF-binding protein-2 by intestinal epithelial (IEC-6) cells: implications for autocrine growth regulation.
    Park JH; McCusker RH; Vanderhoof JA; Mohammadpour H; Harty RF; MacDonald RG
    Endocrinology; 1992 Sep; 131(3):1359-68. PubMed ID: 1380441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cooperativity of the N- and C-terminal domains of insulin-like growth factor (IGF) binding protein 2 in IGF binding.
    Kuang Z; Yao S; McNeil KA; Thompson JA; Bach LA; Forbes BE; Wallace JC; Norton RS
    Biochemistry; 2007 Dec; 46(48):13720-32. PubMed ID: 17985932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of insulin-like growth factor binding protein synthesis and secretion in a bovine epithelial cell line.
    Cohick WS; Clemmons DR
    Endocrinology; 1991 Sep; 129(3):1347-54. PubMed ID: 1714831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation of antisera to mouse insulin-like growth factor binding proteins (IGFBP)-1 to -6: comparison of IGFBP protein and messenger ribonucleic acid localization in the mouse embryo.
    van Kleffens M; Groffen CA; Dits NF; Lindenbergh-Kortleve DJ; Schuller AG; Bradshaw SL; Pintar JE; Zwarthoff EC; Drop SL; van Neck JW
    Endocrinology; 1999 Dec; 140(12):5944-52. PubMed ID: 10579362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mapping of the insulin-like growth factor II binding site of the Type I insulin-like growth factor receptor by alanine scanning mutagenesis.
    Sørensen H; Whittaker L; Hinrichsen J; Groth A; Whittaker J
    FEBS Lett; 2004 May; 565(1-3):19-22. PubMed ID: 15135045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diversity of human insulin-like growth factor (IGF) binding protein-2 fragments in plasma: primary structure, IGF-binding properties, and disulfide bonding pattern.
    Mark S; Kübler B; Höning S; Oesterreicher S; John H; Braulke T; Forssmann WG; Ständker L
    Biochemistry; 2005 Mar; 44(9):3644-52. PubMed ID: 15736974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin-like growth factor binding protein-2: contributions of the C-terminal domain to insulin-like growth factor-1 binding.
    Kibbey MM; Jameson MJ; Eaton EM; Rosenzweig SA
    Mol Pharmacol; 2006 Mar; 69(3):833-45. PubMed ID: 16306230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin-like growth factor (IGF) binding to cell monolayers is directly modulated by the addition of IGF-binding proteins.
    McCusker RH; Busby WH; Dehoff MH; Camacho-Hubner C; Clemmons DR
    Endocrinology; 1991 Aug; 129(2):939-49. PubMed ID: 1713163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of insulin-like growth factor-binding protein-5 by insulin-like growth factor I and interleukin-1alpha in ovine articular chondrocytes.
    Sunic D; McNeil JD; Rayner TE; Andress DL; Belford DA
    Endocrinology; 1998 May; 139(5):2356-62. PubMed ID: 9564845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Binding site for the C-domain of insulin-like growth factor (IGF) binding protein-6 on IGF-II; implications for inhibition of IGF actions.
    Headey SJ; Keizer DW; Yao S; Wallace JC; Bach LA; Norton RS
    FEBS Lett; 2004 Jun; 568(1-3):19-22. PubMed ID: 15196913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors regulating insulin-like growth factor-binding protein-3 binding, processing, and potentiation of insulin-like growth factor action.
    Conover CA; Clarkson JT; Bale LK
    Endocrinology; 1996 Jun; 137(6):2286-92. PubMed ID: 8641177
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin-like growth factor-I (IGF-I) regulates IGFBP-3 and IGFBP-4 by multiple mechanisms in A549 human adenocarcinoma cells.
    Price WA; Moats-Staats BM; Stiles AD
    Am J Respir Cell Mol Biol; 1995 Oct; 13(4):466-76. PubMed ID: 7546777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin-like growth factor-I (IGF-I) and transforming growth factor-beta 1 release IGF-binding protein-3 from human fibroblasts by different mechanisms.
    Martin JL; Ballesteros M; Baxter RC
    Endocrinology; 1992 Oct; 131(4):1703-10. PubMed ID: 1382959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin-like growth factor (IGF) binding to human fibroblast and glioblastoma cells: the modulating effect of cell released IGF binding proteins (IGFBPs).
    McCusker RH; Camacho-Hubner C; Bayne ML; Cascieri MA; Clemmons DR
    J Cell Physiol; 1990 Aug; 144(2):244-53. PubMed ID: 2166057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin-like growth factor binding proteins in fetal rat mesencephalic cultures: regulation by fibroblast growth factor and insulin-like growth factor I.
    Kummer JL; Zawada WM; Freed CR; Chernausek SD; Heidenreich KA
    Endocrinology; 1996 Aug; 137(8):3551-6. PubMed ID: 8754786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perlustrin, a Haliotis laevigata (abalone) nacre protein, is homologous to the insulin-like growth factor binding protein N-terminal module of vertebrates.
    Weiss IM; Göhring W; Fritz M; Mann K
    Biochem Biophys Res Commun; 2001 Jul; 285(2):244-9. PubMed ID: 11444832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of insulin-like growth factor binding protein-3 messenger ribonucleic acid expression by insulin-like growth factor I.
    Bale LK; Conover CA
    Endocrinology; 1992 Aug; 131(2):608-14. PubMed ID: 1379162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cumulative mutagenesis of the basic residues in the 201-218 region of insulin-like growth factor (IGF)-binding protein-5 results in progressive loss of both IGF-I binding and inhibition of IGF-I biological action.
    Allan GJ; Tonner E; Szymanowska M; Shand JH; Kelly SM; Phillips K; Clegg RA; Gow IF; Beattie J; Flint DJ
    Endocrinology; 2006 Jan; 147(1):338-49. PubMed ID: 16195401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.